A citation-based method for searching scientific literature

Robert J Ferrante. Biochim Biophys Acta 2009
Times Cited: 99



S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
Times Cited: 1755




List of shared articles



Times cited

Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.
Dean J Wright, Thibault Renoir, Laura J Gray, Anthony J Hannan. Adv Neurobiol 2017
4

Spatiotemporal analysis of soluble aggregates and autophagy markers in the R6/2 mouse model.
M J Vijay Kumar, Devanshi Shah, Mridhula Giridharan, Niraj Yadav, Ravi Manjithaya, James P Clement. Sci Rep 2021
5


Role of cerebral cortex in the neuropathology of Huntington's disease.
Ana M Estrada-Sánchez, George V Rebec. Front Neural Circuits 2013
54

Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences.
Claudia Rangel-Barajas, George V Rebec. Curr Protoc Neurosci 2018
13


Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review.
Musthafa Mohamed Essa, Marzieh Moghadas, Taher Ba-Omar, M Walid Qoronfleh, Gilles J Guillemin, Thamilarasan Manivasagam, Arokiasamy Justin-Thenmozhi, Bipul Ray, Abid Bhat, Saravana Babu Chidambaram,[...]. Neurotox Res 2019
26

Gene expression and behaviour in mouse models of HD.
K R Bowles, S P Brooks, S B Dunnett, L Jones. Brain Res Bull 2012
20

Cell-based treatments for huntington's disease.
Stephen B Dunnett, Anne E Rosser. Int Rev Neurobiol 2011
10

DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease.
Bhagyashree S Joshi, Sameh A Youssef, Reinier Bron, Alain de Bruin, Harm H Kampinga, Inge S Zuhorn. iScience 2021
6

Cortical metabolites as biomarkers in the R6/2 model of Huntington's disease.
Lori Zacharoff, Ivan Tkac, Qingfeng Song, Chuanning Tang, Patrick J Bolan, Silvia Mangia, Pierre-Gilles Henry, Tongbin Li, Janet M Dubinsky. J Cereb Blood Flow Metab 2012
44

Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
Jana Miniarikova, Melvin M Evers, Pavlina Konstantinova. Mol Ther 2018
21

Protein aggregates in Huntington's disease.
Montserrat Arrasate, Steven Finkbeiner. Exp Neurol 2012
205

Pathogenic mechanisms in Huntington's disease.
Lesley Jones, Alis Hughes. Int Rev Neurobiol 2011
24

Early autophagic response in a novel knock-in model of Huntington disease.
Mary Y Heng, Duy K Duong, Roger L Albin, Sara J Tallaksen-Greene, Jesse M Hunter, Mathieu J Lesort, Alex Osmand, Henry L Paulson, Peter J Detloff. Hum Mol Genet 2010
89

Axonopathy in Huntington's disease.
Jia-Yi Li, Laura Conforti. Exp Neurol 2013
29